المؤلفون: S. Rakul A., K. Pozdnyakov V., R. Eloev A., С. Ракул А., К. Поздняков В., Р. Елоев А.

المصدر: Cancer Urology; Том 17, № 2 (2021); 34-45 ; Онкоурология; Том 17, № 2 (2021); 34-45 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: kidney cancer, partial nephrectomy, complication, laparoscopic partial nephrectomy, robot-assisted partial nephrectomy, рак почки, резекция почки, осложнение, лапароскопическая резекция почки, робот-ассистированная резекция почки

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1419/1267; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1419/967; Kates M., Badalato G.M., Pitman M., McKiernan J.M. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186(4):1247-53. DOI:10.1016/j.juro.2011.05.054.; Kaushik D., Kim S.P., Childs M.A. et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 2013;64(4):600-6. DOI:10.1016/j.eururo.2012.12.023.; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913-24. DOI:10.1016/j.eururo.2015.01.005.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520-9. DOI:10.1016/j.juro.2017.04.100.; Porpiglia F., Mari A., Bertolo R. et al. Partial nephrectomy in clinical T1b renal tumors: multicenter comparative study of open, laparoscopic and robot-assisted approach (the record project). Urology 2016;89:45-51. DOI:10.1016/j.urology.2015.08.049.; Furukawa J., Kanayama H., Azuma H. et al. “Trifecta” outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study. J Clin Oncol 2020;25(2):347-53. DOI:10.1007/s10147-019-01565-0.; Choi J.E., You J.H., Kim D.K. et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol 2015;67(5):891-901. DOI:10.1016/j.eururo.2014.12.028.; Cacciamani G., Medina L.G., Gill T. et al. Impact of surgical factors on robotic partial nephrectomy outcomes: comprehensive systematic review and metaanalysis. J Urol 2018;200(2):258-74. DOI:10.1016/j.juro.2017.12.086.; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51(6):1606-15. DOI:10.1016/j.eururo.2006.11.013.; Rosenthal R., Hoffmann H., Clavien P.A. et al. Definition and Classification of intraoperative complications (CLASSIC): delphi study and pilot evaluation. J Surg 2015;39(7):1663-71. DOI:10.1007/s00268-015-3003-y.; Clavien P.A., Barkun J., de Oliveira M.L. et al. The Clavien-Dindo classification of surgical complications: five year experience. Ann Surg 2009;250(2):187-96. DOI:10.1097/SLA.0b013e3181b13ca2.; Larson J.A., Kaouk J.H., Stifelman M.D. et al. Nonmodifiable factors and complications contribute to length of stay in robot-assisted partial nephrectomy. J Endourol 2015;29(4):422-9. DOI:10.1089/end.2014.0424.; Larcher A., Fossati N., Mistretta F. et al. Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses. Urol Oncol 2015;33(1):22.e1-9. DOI:10.1016/j.urolonc.2014.09.003.; Arora S., Keeley J., Pucheril D. et al. What is the hospital volume threshold to optimize inpatient complication rate after partial nephrectomy? Urol Oncol 2018;36(7):339.e17-23. DOI:10.1016/j.urolonc.2018.04.009.; Hadjipavlou M., Khan F., Fowler S. et al. Partial vs radical nephrectomy for T1 renal tumors: an analysis from the British association of urological surgeons nephrectomy audit. BJU Int 2016;117(1):62-71. DOI:10.1111/bju.13114.; Bigot P., Hetet J.F., Bernhard J.C. et al. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity and functional and oncological outcomes. Clin Genitourin Cancer 2014;12(1):e19-27. DOI:10.1016/j.clgc.2013.09.004.; Tomaszewski J.J., Cung B., Smaldone M.C. et al. Renal pelvic anatomy is associated with incidence, grade, and need for intervention for urine leak following partial nephrectomy. Eur Urol 2014;66(5):949-55. DOI:10.1016/j.eururo.2013.10.009.; Tomaszewski J.J., Smaldone M.C., Cung B. et al. Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology 2014;84(2):351-7. DOI:10.1016/j.urology.2014.05.001.; Kim S.P., Campbell S.C., Gill I. et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses. Eur Urol 2017;72(1):64-75. DOI:10.1016/j.eururo.2016.11.038.; Banapour P., Abdelsayed G.A., Bider-Canfield Z. et al. Nephrometry score matched robotic vs. laparoscopic vs. open partial nephrectomy. J Robot Surg 2018;12(4):679-85. DOI:10.1007/s11701-018-0801-x.; Jang H.J., Song W., Suh Y.S. et al. Comparison of perioperative outcomes of robotic versus laparoscopic partial nephrectomy for complex renal tumors (RENAL nephrometry score of 7 or higher). Korean J Urol 2014;55(12):808-13. DOI:10.4111/kju.2014.55.12.808.; Lista G., Buffi N.M., Lughezzani G. et al. Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project). Urology 2015;85(3):589-95. DOI:10.1016/j.urology.2014.09.068.; Mathieu R., Verhoest G., Droupy S. et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 2013;112(4):E283-9. DOI:10.1111/bju.12222.; Buffi N.M., Saita A., Lughezzani G. et al. Robot-assisted partial nephrectomy for complex (PADUA Score >10) tumors: techniques and results from a multicenter experience at four high-volume centers. Eur Urol 2020;77(1):95-100. DOI:10.1016/j.eururo.2019.03.006.; Krane L.S., Manny T.B., Mufarrij P.W. et al. Does experience in creating a robot-assisted partial nephrectomy (RAPN) programme in an academic centre impact outcomes or complication rate? BJU Int 2013;112(2):207-15. DOI:10.1111/bju.12160.; https://oncourology.abvpress.ru/oncur/article/view/1419

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1419
https://doi.org/10.17650/1726-9776-2021-17-2-34-45

المؤلفون: S. Petrov B., Ye. Veliyev I., R. Yeloyev A., I. Lysenko S., С. Петров Б., Е. Велиев И., Р. Елоев А., И. Лысенко С.

المصدر: Cancer Urology; Том 2, № 3 (2006); 37-39 ; Онкоурология; Том 2, № 3 (2006); 37-39 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2006-2-3

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1167/1052; Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 31: 8–31.; Матвеев Б.П., Бухаркин Б.В., Матвеев В.Б. Рак предстательной железы. М.; 1999. с. 5.; Djavan B., Zlotta A.R., Remzi M. et al. Optimal predictors of prostate cancer in repeat prostate biopsy: a prospective study in 1051 men. J Urol 2000; 163(4): 1144–8.; Seidman H., Mushinski M.H., Gelb S.K., Silverberg E. Probabilities of eventually developing or dying of cancer in United States 1985. CA Cancer J Clin 1985; 35: 36–56.; Morgan T.O., McLeod D.G., Leifer E.S. et al. Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen. Urology 1996; 48: 76–80.; Djavan B., Remzi M., Marberger M. When and how a prostatic rebiopsy should be performed? Eur Urol Suppl 2002;1 (6): 52–9.; Hendrikx A., Safarik L., Hammerer P. TRUS and biopsy: practical aspects. Eur Urol 2002; 41(6): 1–10.; Gretzer M.B., Partin A.W. PSA levels and the probability of prostate cancer on biopsy. Eur Urol Suppl 2002; 1 (6): 21–7.; https://oncourology.abvpress.ru/oncur/article/view/1167

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1167
https://doi.org/10.17650/1726-9776-2006-2-3-37-39

المؤلفون: S. Rakul A., K. Pozdnyakov V., R. Eloev A., N. Pliskachevskiy A., С. Ракул А., К. Поздняков В., Р. Елоев А., Н. Плискачевский А.

المصدر: Cancer Urology; Том 14, № 2 (2018); 44--53 ; Онкоурология; Том 14, № 2 (2018); 44--53 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-2

مصطلحات موضوعية: renal tumor, organ-preserving treatment, robot-assisted nephron sparing, complication, новообразование почки, органсохраняющее лечение, робот-ассистированная резекция почки, лапароскопическая радикальная нефрэктомия, осложнения

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/785/763; Jemal A., Bray F., Centr M.M. et al. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90. DOI:10.3322/caac.20107. PMID: 21296855.; Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. DOI:10.1002/ijc.29210. PMID: 25220842.; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. 250 с.; Huang W.C., Elkin E.B., Levey A.S. et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors – is there a difference in mortality and cardiovascular outcomes? J Urol 2009;181(1):55–61. DOI:10.1016/j.juro.2008.09.017. PMID: 19012918.; Kates M., Badalato G.M., Pitman M., McKiernan J.M. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. J Urol 2011;186(4):1247–53. DOI:10.1016/j.juro.2011.05.054. PMID: 21849201.; Miller D.C., Schonlau M., Litwin M.S. et al. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer 2008;112(3):511–20. DOI:10.1002/cncr.23218. PMID: 18072263.; Kutikov A., Smaldone M.C., Uzzo R.G. Partial versus radical nephrectomy: balancing nephrons and perioperative risk. Eur Urol 2013;64(4):607–9. DOI:10.1016/j.eururo.2013.01.020. PMID: 23375430.; Kaushik D., Kim S.P., Childs M.A. et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 2013;64(4):600–6. DOI:10.1016/j.eururo.2012.12.023. PMID: 23280319.; Ljungberg B., Hanbury D.C., Kuczyk M.A. et al. Renal cell carcinoma guideline. Eur Urol 2007;51(6):1502–10. DOI:10.1016/j.eururo.2007.03.035. PMID: 17408850.; Campbell S., Uzzo R.G., Allaf M.E. et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2017;198(3):520–9. DOI:10.1016/j.juro.2017.04.100. PMID: 28479239.; Лоран О.Б., Серегин А.В., Шустицкий Н.А. Технические особенности при выполнении органосохраняющих операций по поводу рака почки. Медицинский вестник Башкортостана 2013;8(2):197–201. [; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;(3):22–30. [; Алексеев Б.Я., Анжиганова Ю.В., Лыков А.В. и др. Особенности диагностики и лечения рака почки в России: предварительные результаты многоцентрового кооперированного исследования. Онкоурология 2012(3):24–30.; Clavien P.A., Barkun J., de Oliveira M.L. et al. The Clavien–Dindo classification of surgical complications: five year experience. Ann Surg 2009;250(2):187–96. DOI:10.1097/SLA.0b013e3181b13ca2. PMID: 19638912.; Olbert P.J., Maier M., Heers H. et al. Indications for nephron-sparing surgery. Analysis over a 13-year period in the context of changing guidelines. Urologe A 2015;54(6):804–10. DOI:10.1007/s00120-014-3710-2. PMID: 25503720.; Minervini A., Vittori G., Antonelli A. et al. Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications. World J Urol 2014;32(1):287–93. DOI:10.1007/s00345-013-1136-x. PMID: 23913095.; Sun M., Abdollah F., Shariat S.F. et al. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur J Surg Oncol 2012;38(1):80–7. DOI:10.1016/j.ejso.2011.09.035. PMID: 21996370.; Hadjipavlou M., Khan F., Fowler S. et al. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int 2015;117(1):62–71. DOI:10.1111/bju.13114. PMID: 25754386.; Autorino R., Zargar H., Butler S. et al. Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database. Urology 2015;85(4):843–9. DOI:10.1016/j.urology.2014.11.044. PMID: 25681252.; Meyer C., Hansen J., Becker A. et al. The adoption of nephron-sparing surgery in Europe – a trend analysis in two referral centers from Austria and Germany. Urol Int 2016;96(3):330–6. DOI:10.1159/000442215. PMID: 26699625.; Lista G., Buffi N.M., Lughezzani G. et al. Margin, ischemia, and complications system to report perioperative outcomes of robotic partial nephrectomy: a European Multicenter Observational Study (EMOS project). Urology 2015;85(3):589–95. DOI:10.1016/j.urology.2014.09.068. PMID: 25733270.; Mathieu R., Verhoest G., Droupy S. et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int 2013;112(4):E283–9. DOI:10.1111/bju.12222. PMID: 23879913.; Nogueira L., Katz D., Pinochet R. et al. Critical evaluation of perioperative complications in laparoscopic partial nephrectomy. Urology 2010;75(2):288–94. DOI:10.1016/j.urology.2009.09.036. PMID: 19963244.; Alemozaffar M., Chang S.L., Kacker R. et al. Comparing costs of robotic, laparoscopic, and open partial nephrectomy. J Endourol 2013;27(5):560–5. DOI:10.1089/end.2012.0462. PMID: 23130756.; Mano R., Schulman A., Hakimi A.A. et al. Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway. Urology 2015;85(3):596– 603. DOI:10.1016/j.urology.2014.10.044. PMID: 25586478.; https://oncourology.abvpress.ru/oncur/article/view/785

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/785
https://doi.org/10.17650/1726-9776-2018-14-2-44--53

المؤلفون: A. Shestaev Yu., V. Protoshchak V., L. Sinelnikov M., V. Kardinalova A., R. Yeloev A., А. Шестаев Ю., В. Протощак В., Л. Синельников М., В. Кардиналова А., Р. Елоев А.

المصدر: Cancer Urology; Том 10, № 2 (2014); 62-66 ; Онкоурология; Том 10, № 2 (2014); 62-66 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2014-10-2

مصطلحات موضوعية: prostate cancer, high-intensity focused ultrasound therapy, transurethral resection, dysuria, рак предстательной железы, HIFU-терапия, трансуретральная резекция, расстройства мочеиспускания

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/62/78; Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004. Ann Oncol 2005;16:481–8.; Чиссов В.И., Русаков И.Г. Заболевае-мость раком предстательной железы в Рос-сийской Федерации. Экспер и клин уроло-гия 2011;2–3:6–7.; Аполихин О.И., Сивков А.В., Бешлиев Д.А. и др. Анализ урологической заболеваемо-сти в Российской Федерации в 2002–2009 годах по данным официальной статистики. Экспер и клин урология 2011;1:4–10.; Potters L., Morgenstern C., Calugaru E. et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 2008;179(5 Suppl):20–4.; Thuroff S., Chaussy C. Evolution and outcomes of 3 MHz High intensity focused ultrasound therapy for localized prostate cancer over 15 years. J Urol 2013;190(2):702–10.; Хаметов Р.З. Ультразвуковая абляция и брахитерапия при лечении рака предста-тельной железы. Автореф. дис. … канд. мед.наук. Саратов, 2013.; Шосси К. Мировой опыт HIFU-терапии РПЖ. Экспер и клин урология 2011;2–3:44–7.; Thuroff S., Chaussy C. High-intensity focused ultrasound: complications and adverse events. Mol Urol 2011;4:183–7.; Gelet A., Chapelon J.Y., Poissonnier L. et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004;63:625–9.; Dearnaley D.P., Hall E., Lawrence D. et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2011;92:488–98.; https://oncourology.abvpress.ru/oncur/article/view/62

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/62
https://doi.org/10.17650/1726-9776-2014-10-2-62-66

المؤلفون: S. Petrov B., S. Rakul A., A. Zhivov V., R. Eloyev A., A. Plekhanov Yu., P. Kharchenko V., С. Петров Б., С. Ракул А., А. Живов В., Р. Елоев А., А. Плеханов Ю., П. Харченко В.

المصدر: Cancer Urology; Том 6, № 2 (2010); 45-49 ; Онкоурология; Том 6, № 2 (2010); 45-49 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2010-6-2

مصطلحات موضوعية: prostate cancer, biopsy, digital rectal examination, transrectal ultrasound study, рак предстательной железы, биопсия, пальцевое ректальное исследование, трансректальное ультразвуковое исследование

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/53/68; Hernandez J., Thompson I.M. Prostatespecific antigen: a review of the validation of the most commonly used Cancer biomarker. Cancer 2004;101:894-904.; Teahan S.J., Klotz L.H. Current role of prostate-specific antigen kinetics in managing patients with prostate cancer. Br J Urol Int 2006; 97: 451-5.; Hodge K.K., McNeal J.E., Terris M.K.,Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.; Cooperberg M.R., Broering J.M.,Litwin M.S. et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004;171(4):1393-401.; Shah J.B., McKiernan J.M.,Elkin E.P. et al. Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol 2008;179(1):136-40.; Лоран О.Б. Рак простаты: современный взгляд на проблему. В кн.: Материалы XI съезда урологов России. М., 2007. с. 5-13.; Ильин К.А., Магер В.О., Завацкий С.Е. и др. Анализ результатов биопсий пред-стательной железы в лечебных учрежде-ниях Екатеринбурга за 2000-2006 гг. Он-коурология 2008; (4):33-7.; Sobin L.H., Wittekind C. TNM classification of malignant tumours. 6th ed. Wiley, 2002.; https://oncourology.abvpress.ru/oncur/article/view/53

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/53
https://doi.org/10.17650/1726-9776-2010-6-2-45-49